Highlights STAAR Surgical Company

Equities

STAA

US8523123052

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
42.35 ^USD	-1.19%		-6.94%	+35.69%

05-08	Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating	MT
05-08	Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

STAAR Surgical Company Reports Earnings Results for the First Quarter Ended March 29, 2024	05-07	CI
STAAR Surgical Company Reiterates Earnings Guidance for the Fiscal Year 2024	05-07	CI
STAAR Surgical Company Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision	05-07	CI
STAAR Surgical Shares Jump After Reporting Preliminary Fiscal Q1 Sales	04-04	MT
Sector Update: Health Care Stocks Lean Higher Pre-Bell Thursday	04-04	MT
STAAR Surgical Reports Preliminary Fiscal Q1 Sales; Updates Fiscal 2024 Sales Outlook -- Shares Jump Pre-Bell	04-04	MT
STAAR Surgical Company Provides Sales Guidance for the First Quarter Ended March 29, 2024	04-04	CI
STAAR Surgical Unveils New EVO ICL Data and Latest Innovation for 2024	04-02	CI
North American Morning Briefing : Inflation Data -2-	03-12	DJ
STAAR Surgical Q4 Earnings, Revenue Rise	02-26	MT
STAAR Surgical Company Affirms Earnings Guidance for the Fiscal Year 2024	02-26	CI
STAAR Surgical Company Reports Earnings Results for the Full Year Ended December 29, 2023	02-26	CI
STAAR Surgical Company Reports Earnings Results for the Fourth Quarter and Full Year Ended December 29, 2023	02-26	CI
Earnings Flash (STAA) STAAR SURGICAL COMPANY Posts Q4 Revenue $76.3M, vs. Street Est of $75.8M	02-26	MT
North American Morning Briefing : Traders Await -2-	02-26	DJ
STAAR Surgical Announces Marketing Deal for EVO ICL With SharpeVision	01-23	MT
STAAR Surgical Company Announces Strategic Agreement in U.S. with SharpeVision	01-23	CI
Staar Surgical Company Provides Sales Guidance for the Fiscal 2024	01-08	CI
STAAR Surgical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-06	CI
Earnings Flash (STAA) STAAR SURGICAL COMPANY Posts Q3 Revenue $80.3M, vs. Street Est of $80.4M	11-01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights STAAR Surgical Company

Equities

STAA

US8523123052

Highlights

Filters